A Rescue Strategy for Handling Unevaluable Patients in Simon's Two Stage Design.

by Lisa Belin, Philippe Broët, Yann De Rycke
Published 2015-01-01

A two-stage design for phase II trials with time-to-event endpoint using restricted follow-up

by Lisa Belin, Yann De Rycke, Philippe Broët
Published 2017-12-01

On the use of propensity scores in case of rare exposure

by David Hajage, Florence Tubach, Philippe Gabriel Steg, Deepak L. Bhatt, Yann De Rycke
Published 2016-03-01

Self-controlled designs in pharmacoepidemiology involving electronic healthcare databases: a systematic review

by Nathalie Gault, Johann Castañeda-Sanabria, Yann De Rycke, Sylvie Guillo, Stéphanie Foulon, Florence Tubach
Published 2017-02-01

Inappropriate Use of Oral Antithrombotic Combinations in an Outpatient Setting and Associated Risks: A French Nationwide Cohort Study

by Lorène Zerah, Dominique Bonnet-Zamponi, Aya Ajrouche, Jean-Philippe Collet, Yann De Rycke, Florence Tubach
Published 2021-05-01

Impact of a Prescription Support Tool to Improve Adherence to the Guidelines for the Prescription of Oral Antithrombotics: The Combi-AT Randomized Controlled Trial Using Clinical V...

by Lorène Zerah, Dominique Bonnet-Zamponi, Agnès Dechartres, Paul Frappé, Marie Hauguel-Moreau, Jean-Philippe Collet, Yann De Rycke, Florence Tubach
Published 2019-11-01

Cervical cancer screening coverage, management of squamous intraepithelial lesions and related costs in France.

by Yann de Rycke, Florence Tubach, Alexandre Lafourcade, Sylvie Guillo, Marie Dalichampt, André Dahlab, Xavier Bresse, Mathieu Uhart, Christine Bergeron, Hélène Borne, Charlotte Cancalon, Audrey Lajoinie, Stève Bénard
Published 2020-01-01

Genomic instability: a stronger prognostic marker than proliferation for early stage luminal breast carcinomas.

by Anne Vincent-Salomon, Vanessa Benhamo, Eléonore Gravier, Guillem Rigaill, Nadège Gruel, Stéphane Robin, Yann de Rycke, Odette Mariani, Gaëlle Pierron, David Gentien, Fabien Reyal, Paul Cottu, Alain Fourquet, Roman Rouzier, Xavier Sastre-Garau, Olivier Delattre
Published 2013-01-01

The molecular subtype classification is a determinant of sentinel node positivity in early breast carcinoma.

by Fabien Reyal, Roman Rouzier, Berenice Depont-Hazelzet, Marc A Bollet, Jean-Yves Pierga, Severine Alran, Remy J Salmon, Virginie Fourchotte, Anne Vincent-Salomon, Xavier Sastre-Garau, Martine Antoine, Serge Uzan, Brigitte Sigal-Zafrani, Yann De Rycke
Published 2011-01-01

External validation of Adjuvant! Online breast cancer prognosis tool. Prioritising recommendations for improvement.

by David Hajage, Yann de Rycke, Marc Bollet, Alexia Savignoni, Martial Caly, Jean-Yves Pierga, Hugo M Horlings, Marc J Van de Vijver, Anne Vincent-Salomon, Brigitte Sigal-Zafrani, Claire Senechal, Bernard Asselain, Xavier Sastre, Fabien Reyal
Published 2011-01-01

Non-sentinel lymph node metastasis prediction in breast cancer with metastatic sentinel lymph node: impact of molecular subtypes classification.

by Fabien Reyal, Catherine Belichard, Roman Rouzier, Emmanuel de Gournay, Claire Senechal, Francois-Clement Bidard, Jean-Yves Pierga, Paul Cottu, Florence Lerebours, Youlia Kirova, Jean-Guillaume Feron, Virginie Fourchotte, Anne Vincent-Salomon, Jean-Marc Guinebretiere, Brigitte Sigal-Zafrani, Xavier Sastre-Garau, Yann De Rycke, Charles Coutant
Published 2012-01-01